da Cunha-Bang, C
Simonsen, J
Rostgaard, K http://orcid.org/0000-0001-6220-9414
Geisler, C
Hjalgrim, H
Niemann, C U
Article History
Received: 8 September 2016
Accepted: 16 September 2016
First Online: 11 November 2016
Competing interests
: CUN received consultancy fees/support outside the current study from Roche, Abbvie, Janssen, Gilead and Novartis; CG received consultancy fees from Sanofi, Celgene and Janssen and consultancy and advisory board fees from Roche outside the current study. The remaining authors declare no conflicts of interests.